CN102533694A - Method for extracting phospholipase A2 from trimeresurus albolabris venin - Google Patents

Method for extracting phospholipase A2 from trimeresurus albolabris venin Download PDF

Info

Publication number
CN102533694A
CN102533694A CN2012100611006A CN201210061100A CN102533694A CN 102533694 A CN102533694 A CN 102533694A CN 2012100611006 A CN2012100611006 A CN 2012100611006A CN 201210061100 A CN201210061100 A CN 201210061100A CN 102533694 A CN102533694 A CN 102533694A
Authority
CN
China
Prior art keywords
phospholipase
venom
sephadex
lyophilize
gray
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012100611006A
Other languages
Chinese (zh)
Inventor
余晓东
和七一
邓疆渝
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Normal University
Original Assignee
Chongqing Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Normal University filed Critical Chongqing Normal University
Priority to CN2012100611006A priority Critical patent/CN102533694A/en
Publication of CN102533694A publication Critical patent/CN102533694A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses a method for extracting phospholipase A2 from trimeresurus albolabris venin. The method comprises the following steps of: pretreating the trimeresurus albolabris venin; performing CM-Sephadex C-50 cation-exchange chromatography; performing Sephadex G-75 gel chromatography; and performing Q-Sepharose FF pre-packed column chromatography to obtain a pure product. The phospholipase A2 is separated and extracted from the trimeresurus albolabris venin; the preparation method is simple, convenient to implement and low in cost; and the obtained phospholipase A2 has high purity.

Description

Extract phospholipase A in a kind of Trimeresurus albolabris (Gray) snake venom 2Method
Technical field
The invention belongs to the biological extraction field, specifically, relate to from a kind of Trimeresurus albolabris (Gray) snake venom and extract phospholipase A 2Method.
Background technology
Phospholipase A 2(phospholipase A 2, PL A 2) extensively be present in the animal venom and mammiferous pancreas liquid of snake venom, bee venom and scorpion venom, it is a kind of Ca 2+Dependent enzyme, the hydrolysis of second acyl key of catalyzing glycerol phosphatide that can be single-minded generates lysophospholipid and lipid acid.This enzyme is mainly similar by a class formation, the protein family of molecular weight about 14KDa formed, and generally contains 6 to 7 pairs of disulfide linkage.Phospholipase A 2Almost be present in the venom of all poisonous snakes; Except enzymic activity, also have multiple physiology, pharmacological action, after one's own heart dysentery; Cell toxicant; Muscle poison, neural poison and NGFF etc., and anticoagulation, haemolysis, hypotensive, platelet aggregation-against are arranged, induce the formation oedema and cause effect such as convulsions.In addition, phospholipase A 2Also having the function that bacteria growing inhibiting, cell death inducing and resistance HIV virus gets into host cell, is the important tool enzyme of the heterogeneous catalysis mechanism of structure of phospholipid and enzyme in research microbial film, the lipoprotein.From the 1950's first to the phospholipase A of cobra-venom 2Study beginning (Wittcoff et al, 1951), existing so far more than 100 kind of phospholipase A 2Come out by purifying, various experiments show the phospholipase A that different types of poisonous snake contains 2Be not quite similar, even the poisonous snake of same kind, also possible difference owing to living environment, and cause the phospholipase A in the venom 2Structure with active bigger difference arranged.Phospholipase A 2This distinctive chemical property and complex physiological functions are not only carried out biological study, constitutional features and toxicological study to it and are had the important in theory meaning, and at aspects such as treatment tumour, cardiovascular disordeies important application prospects are arranged also as medicine.
Trimeresurus albolabris (Gray) is mainly seen in ground such as Guangzhou, Sichuan, Guizhou, Guangxi, Fujian, Yunnan for poisonous snake is arranged.The Trimeresurus albolabris (Gray) snake venom belongs to the blood circulation poison, because its toxin expelling amount is less, can be at once not fatal after the people is bitten, if but untimelyly taking the treatment measure, also can be in peril of one's life.After being bitten by Trimeresurus albolabris (Gray), the wounded shows as wound more and has an intense pain, and it is more than to bleed, and suffers from around the limb red and swollenly, and the local area also blister, blood blister can occur, severe patient symptom such as also might occur spitting blood, have blood in stool.Research report to its venom mainly contains fiber eliminating enzyme, Thrombin-like enzyme, 5 '-phosphonuclease etc. in recent years, and the Shang Weiyou report separates the preparation phospholipase A from the Trimeresurus albolabris (Gray) snake venom 2Method and phospholipase A thereof 2The research of zymologic property.
Summary of the invention
For solving above technical problem, the object of the present invention is to provide in a kind of Trimeresurus albolabris (Gray) snake venom and extract phospholipase A 2Method.
The present invention seeks to realize like this: extract phospholipase A in a kind of Trimeresurus albolabris (Gray) snake venom 2Method, it is characterized in that: carry out as follows:
(1) Trimeresurus albolabris (Gray) snake venom pre-treatment: collect venom, the venom lyophilize is powdered subsequent use, get thick malicious lyophilized powder 0.3~1g, be dissolved in 5ml pH 5.2-5.8, in 0.025~0.05mol sodium-acetate buffer, frozen centrifugation, it is for use to get supernatant;
(2) CM-Sephadex C-50 cation-exchange chromatography: use pH 5.2-5.8,0.025~0.05mol/L sodium-acetate buffer balance CM-Sephadex C-50 positively charged ion chromatography post; With appearance on the supernatant in the step (1), with the above-mentioned buffer solution for gradient elution of concentration range, detect wavelength: 280nm at 0~0.5mol/L NaCl, flow velocity: 0.5~1ml/min collects the 3ml/ pipe, collects the strongest active peak I, lyophilize;
(3) Sephadex G-75 gel chromatography: with pH 7.5~8.0,0.01~0.03mol/L Tris-HCl buffer balance Sephadex G-75 post is gone up appearance with the freeze-drying sample of collecting in the step (2) with same buffer dissolving back; Detect wavelength: 280nm; Flow velocity 0.15ml/min collects the 2ml/ pipe, surveys each peak phospholipase activity; Collect the strongest active peak IV, lyophilize;
(4) Q-Sepharose FF prepacked column chromatography: with pH 7.5~7.8; 0.02 the Tris-HC1 damping fluid balance Q-Sepharose FF prepacked column of~0.05mol/L is gone up appearance with making the freeze-drying sample in the step (3) with above-mentioned damping fluid dissolving back, with the above-mentioned buffer solution for gradient elution of concentration range at 0~0.5mol/L NaCl; Flow velocity 1ml/min; The 1ml/ pipe is collected active peak II, and lyophilize promptly gets pure article.
Adopt in the above-mentioned steps (1) and sting ware extrusion process collection venom, wherein cool off the centrifugal 10~15min of centrifugal employing 3000~5000r/min.
All detect the OD280nm light absorption value in the chromatography process, adopt the egg plate method to measure phospholipase activity.Adopt SDS-polyacrylamide gel electrophoresis determining molecular weight size.
Adopt egg plate to measure phospholipase A 2Active: take by weighing agarose 0.15g, be added to 100ml and contain 1mol/L NaCl, in the solution of 0.005M/L CaCl2, high-temperature sterilization 15min gets new fresh hen egg, the aseptic egg yolk liquid of getting of ethanol.After having sterilized, wait be cooled to 50 ℃ after, add the abundant mixing of egg yolk liquid 4ml by every 100ml substratum after, bed board, treat that gelling is solid after, the punch tool punching, every hole adds the 10ul testing sample, places 20h for 50 ℃, observes flat board and transparent circle whether occurs, if phospholipase A is arranged 2Transparent circle will appear in activity; If no, then transparent circle can not occur.
Beneficial effect: the present invention's separation and Extraction from the Trimeresurus albolabris (Gray) snake venom has gone out a kind of phospholipase A 2, the preparation method is simple, be convenient to operation, with low cost, and the gained phospholipase A 2Purity is higher.
Figure of description
Fig. 1 is a CM-Sephadex C-50 cation-exchange chromatography collection of illustrative plates;
Fig. 2 is a Sephadex G-75 gel chromatography collection of illustrative plates;
Fig. 3 is a Q-Sepharose FF prepacked column chromatography collection of illustrative plates;
Fig. 4 prepares phospholipase A for the present invention 2The SDS-PAGE collection of illustrative plates.
Embodiment
Embodiment 1
(1) Trimeresurus albolabris (Gray) snake venom pre-treatment: adopt and sting ware extrusion process collection venom; The venom lyophilize is powdered subsequent use; Get thick malicious lyophilized powder 0.3g, be dissolved in 5ml pH 5.2, in the 0.025mol/L sodium-acetate buffer; 3000~5000r/min frozen centrifugation, 10~15min, it is for use to get supernatant.
(2) CM-Sephadex C-50 cation-exchange chromatography: with pH 5.2,0.025mol/L sodium-acetate buffer balance CM-Sephadex C-50 positively charged ion chromatography post; With appearance on the supernatant in the step (1), with the above-mentioned buffer solution for gradient elution of concentration range at 0~0.5mol/L NaCl.Detect wavelength: 280nm, flow velocity: 1ml/min collects 3ml/ pipe (referring to Fig. 1).Collect the strongest active peak I, lyophilize.
(3) Sephadex G-75 gel chromatography: with pH 7.5; 0.25mol/L Tris-HCl buffer balance Sephadex G-75 post; The freeze-drying sample of collecting in the step (2) is gone up appearance with same buffer dissolving back; Detect wavelength: 280nm, flow velocity 0.15ml/min collects 2ml/ pipe (referring to Fig. 2).Survey each peak phospholipase activity, collect the strongest active peak IV, lyophilize.
(4) Q-Sepharose FF prepacked column chromatography: with pH 7.5, the Tris-HC1 damping fluid balance Q-Sepharose FF prepacked column of 0.25mol/L.Go up appearance with making the freeze-drying sample in the step (3) with above-mentioned damping fluid dissolving back, with the above-mentioned buffer solution for gradient elution of concentration range at 0~0.5mol/L NaCl, flow velocity 1ml/min, 1ml/ manages (referring to Fig. 3).Collect active peak II, lyophilize promptly gets pure article.
(5) molecular-weight determination: use the SDS-polyacrylamide gel electrophoresis, resolving gel concentration is 12%.The result is as shown in Figure 4, and through above-mentioned purification step, sample is shown as a protein band, and molecular weight is 17200 dalton.
Embodiment 2
(1) Trimeresurus albolabris (Gray) snake venom pre-treatment: adopt and sting ware extrusion process collection venom, the venom lyophilize is powdered subsequent use, get thick malicious lyophilized powder 1g; Be dissolved in 5ml pH 5.8; 0.03mol/L in the sodium-acetate buffer, 5000r/min frozen centrifugation 15min, it is for use to get supernatant.
(2) CM-Sephadex C-50 cation-exchange chromatography: with pH 5.8,0.03mol/L sodium-acetate buffer balance CM-Sephadex C-50 positively charged ion chromatography post; With appearance on the supernatant in the step (1), with the above-mentioned buffer solution for gradient elution of concentration range at 0~0.5mol/L NaCl.Detect wavelength: 280nm, flow velocity: 0.5ml/min collects the 3ml/ pipe.Collect the strongest active peak I, lyophilize.
(3) Sephadex G-75 gel chromatography: with pH 7.8; 0.2mol/L Tris-HCl buffer balance Sephadex G-75 post is gone up appearance with the freeze-drying sample of collecting in the step (2) with same buffer dissolving back, detects wavelength: 280nm; Flow velocity 0.15ml/min collects the 2ml/ pipe.Survey each peak phospholipase activity, collect the strongest active peak IV, lyophilize.
(4) Q-Sepharose FF prepacked column chromatography: with pH 7.8, the Tris-HC1 damping fluid balance Q-Sepharose FF prepacked column of 0.4mol/L.Go up appearance with making the freeze-drying sample in the step (3) with above-mentioned damping fluid dissolving back, with the above-mentioned buffer solution for gradient elution of concentration range at 0~0.5mol/L NaCl, flow velocity 1ml/min, 1ml/ pipe.Collect active peak II, lyophilize promptly gets pure article.

Claims (2)

1. extract phospholipase A in a Trimeresurus albolabris (Gray) snake venom 2Method, it is characterized in that: carry out as follows:
(1) Trimeresurus albolabris (Gray) snake venom pre-treatment: collect venom, the venom lyophilize is powdered subsequent use, get thick malicious lyophilized powder 0.3~1g, be dissolved in 5ml pH 5.2-5.8, in 0.025~0.05mol sodium-acetate buffer, frozen centrifugation, it is for use to get supernatant;
(2) CM-Sephadex C-50 cation-exchange chromatography: use pH 5.2-5.8,0.025~0.05mol/L sodium-acetate buffer balance CM-Sephadex C-50 positively charged ion chromatography post; With appearance on the supernatant in the step (1), with the above-mentioned buffer solution for gradient elution of concentration range, detect wavelength: 280nm at 0~0.5mol/L NaCl, flow velocity: 0.5~1ml/min collects the 3ml/ pipe, collects the strongest active peak I, lyophilize;
(3) Sephadex G-75 gel chromatography: with pH 7.5~8.0,0.01~0.03mol/L Tris-HCl buffer balance Sephadex G-75 post is gone up appearance with the freeze-drying sample of collecting in the step (2) with same buffer dissolving back; Detect wavelength: 280nm; Flow velocity 0.15ml/min collects the 2ml/ pipe, surveys each peak phospholipase activity; Collect the strongest active peak IV, lyophilize;
(4) Q-Sepharose FF prepacked column chromatography: with pH 7.5~7.8; 0.02 the Tris-HC1 damping fluid balance Q-Sepharose FF prepacked column of~0.05mol/L is gone up appearance with making the freeze-drying sample in the step (3) with above-mentioned damping fluid dissolving back, with the above-mentioned buffer solution for gradient elution of concentration range at 0~0.5mol/L NaCl; Flow velocity 1ml/min; The 1ml/ pipe is collected active peak II, and lyophilize promptly gets pure article.
2. according to extracting phospholipase A in the said a kind of Trimeresurus albolabris (Gray) snake venom of claim 1 2Method, it is characterized in that: adopt in the said step (1) and sting the ware extrusion process and collect venom, wherein cool off the centrifugal 10~15min of centrifugal employing 3000~5000r/min.
CN2012100611006A 2012-03-09 2012-03-09 Method for extracting phospholipase A2 from trimeresurus albolabris venin Pending CN102533694A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012100611006A CN102533694A (en) 2012-03-09 2012-03-09 Method for extracting phospholipase A2 from trimeresurus albolabris venin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012100611006A CN102533694A (en) 2012-03-09 2012-03-09 Method for extracting phospholipase A2 from trimeresurus albolabris venin

Publications (1)

Publication Number Publication Date
CN102533694A true CN102533694A (en) 2012-07-04

Family

ID=46341728

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012100611006A Pending CN102533694A (en) 2012-03-09 2012-03-09 Method for extracting phospholipase A2 from trimeresurus albolabris venin

Country Status (1)

Country Link
CN (1) CN102533694A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109715176A (en) * 2016-06-24 2019-05-03 金容隨 The method of the purification bee venom of removal allergic component and the purification bee venom of the removal allergic component prepared by the method are prepared using yolk
CN109929020A (en) * 2017-12-15 2019-06-25 浙江京新药业股份有限公司 A kind of purification process of cobra venom and products thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1846713A (en) * 2005-04-13 2006-10-18 上海医药工业研究院 Snake venom extract for preventing and treating pyemia
CN101265469A (en) * 2008-04-07 2008-09-17 重庆师范大学 Method for preparing trimeresurus albolabris snake venom 5'-nucleotidase

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1846713A (en) * 2005-04-13 2006-10-18 上海医药工业研究院 Snake venom extract for preventing and treating pyemia
CN101265469A (en) * 2008-04-07 2008-09-17 重庆师范大学 Method for preparing trimeresurus albolabris snake venom 5'-nucleotidase

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
李顺意等: "竹叶青蛇毒五种磷脂酶A2的分离纯化和氨基酸序列分析", 《湖北大学学报(自然科学版)》 *
邓疆渝邓: "竹叶青属毒蛇的毒素研究进展", 《生物学杂志》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109715176A (en) * 2016-06-24 2019-05-03 金容隨 The method of the purification bee venom of removal allergic component and the purification bee venom of the removal allergic component prepared by the method are prepared using yolk
CN109929020A (en) * 2017-12-15 2019-06-25 浙江京新药业股份有限公司 A kind of purification process of cobra venom and products thereof

Similar Documents

Publication Publication Date Title
Fan et al. Epimedium polysaccharide and propolis flavone can synergistically stimulate lymphocyte proliferation in vitro and enhance the immune responses to ND vaccine in chickens
CN103989713B (en) Immunopotentiating composition and its manufacture method
CN102153668B (en) Anticancer Armillaria luteovirens polysaccharide and extraction process thereof
CN103800390B (en) Health-care product with immunity-reinforcing and liver-protecting functions, preparation method and application thereof
WO2019205662A1 (en) C. militaris medium polysaccharide, method for separating and purifying same, and use of same
CN101736055A (en) Method for extracting auricularia auricula polysaccharides
CN103130909A (en) Preparation method of selenium-rich Morchella polysaccharide
CN102533694A (en) Method for extracting phospholipase A2 from trimeresurus albolabris venin
CN102260728B (en) Royal jelly polypeptide and application thereof
CN104888213A (en) Preparation method of classical swine fever spleen-lymph-sourced compound living vaccine
CN105504085B (en) Cordyceps militaris glucan and its preparation method and application
CN101820891B (en) BCG polysaccharide nucleic acid extractive and preparation method thereof
CN103059112A (en) Method of extracting anti-intestinal cancer active protein from nostoc commune
CN102229670A (en) Method for extracting immune globulin from yak blood
CN101933976B (en) Method for preparing nanoemulsion from high-efficient active sites of fructus forsythiae essential oil
CN104873971A (en) Diluent for hog cholera live vaccine (spleen and lymph tissue origin)
CN101716332B (en) Use of phycocyanin for preventing and treating diabetes mellitus
CN101709083B (en) Fibrinolytic protein from scorpion tails, preparation method and application thereof
CN103588859A (en) Centipede active peptide and application thereof in pharmacy
CN102816226A (en) Preparation method of porcine small intestine antibacterial peptides PR39
CN101967499A (en) Method for producing reduced coenzyme Q10
CN101686992B (en) Use of extractive of BCG polysaccharide and nucleic acid for preparing medicine for treating allergic dermatosis, and its injection and preparation method
CN104095833B (en) Diphenyl ether compound is preparing the purposes in beta-amyloid aggregation inhibitor
CN104306455B (en) A kind of Plumula Nelumbinis chloroform extract and its production and use
CN102309528B (en) Preparation method of active substance capable of resisting neurodegenerative disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120704